Results 111 to 120 of about 5,939 (158)

Case Report: Successful treatment of SAPHO syndrome refractory to adalimumab with upadacitinib. [PDF]

Front Immunol
Du J, Li Y, Geng S, Li C, Shang S.
europepmc   +1 more source

Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD). [PDF]

Open Access Rheumatol
Almoallim HM, Bahlas SM, Bawazir Y, Hussein AH, Attia GM, Manasfi H, Bafadhl ZA, Asiri AM, Ali AR, Alomair MM, Alsharaif MM, Almalki HH, Siddiqui MI, Alhazmi AS, Attar SM.   +14 more
europepmc   +1 more source

Prompt recurrence of granuloma annulare upon Janus kinase inhibitor discontinuation. [PDF]

JAAD Case Rep
Haveric A, Zhao P, Markeson CD, Hsu S.
europepmc   +1 more source

Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. [PDF]

Acta Derm Venereol
Andersen YMF, Seyed-Alinaghi F, Kristiansen MF, Thomsen SF.   +3 more
europepmc   +1 more source

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis. [PDF]

Front Pharmacol
Ramonda R, Lorenzin M, Carletto A, Chimenti MS, Manara M, Cozzi G, Zabotti A, Foti R, Carriero A, Hoxha A, Selmi C, Raffeiner B, Giollo A, Cauli A, Salvarani C, Atzeni F, Rossini M, Fassio A, Nava F, Paci V, Moroncini G, Buonanno S, Frediani B, Luchetti Gentiloni MM, Gentileschi S.   +24 more
europepmc   +1 more source

Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab. [PDF]

Crohns Colitis 360
Han J, Puangampai A, Man B, Kandah HM, Rubin DT, Choi DK.   +5 more
europepmc   +1 more source

A multicentered retrospective cohort study comparing JAK inhibitor therapies in moderate-to-severe ulcerative colitis. [PDF]

Crohns Colitis 360
Kumar A, Baxter J, Rimmer P, Noble B, Bower J, Makki MU, Hatta A, Chikhlia A, Cheesbrough J, Disney B, Muir J, Karova M, Butterworth J, Sagar N, Al-Talib I, Nahal J, Ali N, Sagar V, Varyani F, Smith S, Bourne S, Hsu YK, Eltahir A, de Silva S, Harvey P.   +24 more
europepmc   +1 more source

Off-Label Use of Upadacitinib for Treatment of Lichen Planus: A Narrative Review. [PDF]

Dermatol Pract Concept
Gregory M, Esfandiari N, Daveluy S.
europepmc   +1 more source

Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with <i>COL7A1</i>, <i>CARD14</i>, and <i>G6PD</i> gene mutations. [PDF]

Front Med (Lausanne)
Li H, Zhang Y, Lin X, Yan T, Wu X, Zhang Z.   +5 more
europepmc   +1 more source

Case Report: Upadacitinib treatment for Behçet's syndrome with intestinal damage. [PDF]

Front Med (Lausanne)
Yuan L, Sun Y, Yan J.
europepmc   +1 more source